Immune dysfunction revealed by digital spatial profiling of immuno-oncology markers in progressive stages of renal cell carcinoma and in brain metastases
Background The tumor microenvironment (TME) contributes to cancer progression and treatment response to therapy, including in renal cell carcinoma (RCC). Prior profiling studies, including single-cell transcriptomics, often involve limited sample sizes and lack spatial orientation. The TME of RCC br...
Saved in:
Main Authors: | Wei Wei, Michael Hurwitz, Sabina Signoretti, Lucia Jilaveanu, Toni K Choueiri, David L Rimm, Adebowale Adeniran, Sandra Martínez, Harriet M Kluger, David A Schoenfeld, Myrto Moutafi, Dijana Djureinovic, Ross D Merkin, David A Braun, Fabio Parisi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2023-08-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/11/8/e007240.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Leveraging mRNA technology for antigen based immuno-oncology therapies
by: Wei Zheng, et al.
Published: (2025-01-01) -
Opportunities and challenges of immuno-oncology: A bibliometric analysis from 2014 to 2023
by: Siqi Zhang, et al.
Published: (2025-12-01) -
Next-generation ctDNA-driven clinical trials in precision immuno-oncology
by: Charu Aggarwal, et al.
Published: (2023-01-01) -
Humanized Mouse Models for Immuno-Oncology Research: A Review and Implications in Lung Cancer Research
by: Cheol-Kyu Park, MD, PhD, et al.
Published: (2025-03-01) -
Teaching an old dog new tricks: re-engineering IL-2 for immuno-oncology applications
by: Mario Sznol, et al.
Published: (2023-01-01)